Moreover, they can selectively activate ERK1/2 and p38 and regulate MAPK/p38 and ERK1/2 signaling pathways to induce apoptosis in CRC cells (Su et al., 2018). This evidence concerns the gene MAPK3 and colorectal carcinoma.